Pharma Stocks

Should You Be Adding Bliss GVS Pharma (NSE:BLISSGVS) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a…

Read More »

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Strength And Long Term Gains

Amneal Pharmaceuticals (AMRX) is back in focus after recent trading that left the stock with a 1 day gain of…

Read More »

Bristol Myers Squibb’s Mezigdomide Data Reframes Multiple Myeloma Pipeline Story

Bristol Myers Squibb (NYSE:BMY) reported landmark positive Phase 3 SUCCESSOR-2 results for mezigdomide in relapsed or refractory multiple myeloma. The…

Read More »

TSX Specialty Pharma Stocks Tracking Therapy Market Growth

Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…

Read More »

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, MA, May 29, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE),…

Read More »

Why Is Ionis Pharmaceuticals (IONS) Up 3.4% Since Last Earnings Report?

It has been about a month since the last earnings report for Ionis Pharmaceuticals (IONS). Shares have added about 3.4%…

Read More »

Canadian Healthcare Stocks Expanding Through Specialty Pharma Growth

Disclaimer The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos,…

Read More »

Merck Stock After a 60% Rally From Its Lows: Is It Still Worth Buying at $120?

Key Takeaways: MRK stock has rallied around 60% over the past year, climbing from a 52-week low of $75 to…

Read More »

Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

WESTCHESTER, Ill., May 28, 2026 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for…

Read More »

Is SynAct Pharma (STO:SYNACT) In A Good Position To Deliver On Growth Plans?

Just because a business does not make any money, does not mean that the stock will go down. For example,…

Read More »